CRLCharles River Laboratories

Health care · Research Services · NYSE

We began operating in 1947 and, since then, have undergone several changes to our business structure. 10-K, Item 1

Employees: 19,700
Headquarters: Wilmington, MA
CEO: Birgit Girshick
Next results: around Jan 12, 2027

CRL and 9 peers, year by year

The 9 Health care companies closest to CRL in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
CRL Charles River Laboratories	FY2025	$4.0B	−0.9%	-	0.6%	−3.6%	12.9%	−4.6%	0.68
ALGN Align Technology	FY2025	$4.0B	+0.9%	67.2%	13.5%	10.2%	12.2%	10.1%	-
MTD Mettler Toledo	FY2025	$4.0B	+4.0%	59.4%	-	21.6%	21.1%	n/m	n/m
COO Cooper Companies	FY2025	$4.1B	+5.1%	65.5%	16.7%	9.2%	10.6%	4.6%	0.30
VEEV Veeva Systems	FY2026	$3.2B	+16.3%	75.5%	28.7%	28.4%	-	12.6%	-
ILMN Illumina, Inc.	FY2025	$4.3B	−0.7%	66.1%	18.6%	19.6%	21.4%	31.2%	0.73
WST West Pharmaceutical Services	FY2025	$3.1B	+6.3%	35.9%	19.0%	16.1%	15.3%	15.5%	0.06
WAT Waters Corporation	FY2025	$3.2B	+7.0%	-	25.4%	20.3%	17.1%	25.1%	0.55
IDXX Idexx Laboratories	FY2025	$4.3B	+10.4%	61.8%	31.6%	24.6%	24.6%	66.0%	0.28
PODD Insulet Corporation	FY2025	$2.7B	+30.7%	71.6%	17.5%	9.1%	13.9%	16.3%	0.63

Revenuepeer median $4.0B

Sales growthpeer median +6.3%

Gross marginpeer median 65.8%

Operating marginpeer median 18.8%

Net marginpeer median 19.6%

FCF marginpeer median 16.2%

Return on equitypeer median 15.9%

Debt / equitypeer median 0.43

ILMN 0.73
CRL 0.68
PODD 0.63
WAT 0.55
COO 0.30
IDXX 0.28
WST 0.06
ALGN -
MTD n/m
VEEV -

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	$1.7B	$1.9B	$2.3B	$2.6B	$2.9B	$3.5B	$4.0B	$4.1B	$4.0B	$4.0B
ALGN Dec	$1.1B	$1.5B	$2.0B	$2.4B	$2.5B	$4.0B	$3.7B	$3.9B	$4.0B	$4.0B
MTD Dec	$2.5B	$2.7B	$2.9B	$3.0B	$3.1B	$3.7B	$3.9B	$3.8B	$3.9B	$4.0B
COO Oct	$2.0B	$2.1B	$2.5B	$2.7B	$2.4B	$2.9B	$3.3B	$3.6B	$3.9B	$4.1B
VEEV Jan	$409.2M	$550.5M	$690.6M	$862.2M	$1.1B	$1.9B	-	$2.2B	$2.4B	$2.7B
ILMN Dec	$2.4B	$2.8B	$3.3B	$3.5B	$3.2B	$4.5B	$4.6B	$4.5B	$4.4B	$4.3B
WST Dec	$1.5B	$1.6B	$1.7B	$1.8B	$2.1B	$2.8B	$2.9B	$2.9B	$2.9B	$3.1B
WAT Dec	$2.2B	$2.3B	$2.4B	$2.4B	$2.4B	$2.8B	$3.0B	$3.0B	$3.0B	$3.2B
IDXX Dec	$1.8B	$2.0B	$2.2B	$2.4B	$2.7B	$3.2B	$3.4B	$3.7B	$3.9B	$4.3B
PODD Dec	$367.0M	$463.8M	$563.8M	$738.2M	$904.4M	$1.1B	$1.3B	$1.7B	$2.1B	$2.7B
Peer median	$1.8B	$2.0B	$2.2B	$2.4B	$2.4B	$2.9B	$3.3B	$3.6B	$3.9B	$4.0B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	+23.3%	+10.5%	+22.0%	+15.7%	+11.5%	+21.1%	+12.3%	+3.9%	−1.9%	−0.9%
ALGN Dec	+27.7%	+36.4%	+33.5%	+22.4%	+2.7%	+59.9%	−5.5%	+3.4%	+3.5%	+0.9%
MTD Dec	+4.7%	+8.6%	+7.7%	+2.5%	+2.5%	+20.5%	+5.4%	−3.4%	+2.2%	+4.0%
COO Oct	+9.4%	+8.8%	+18.4%	+4.8%	−8.4%	+20.2%	+13.2%	+8.6%	+8.4%	+5.1%
VEEV Jan	-	+32.9%	+25.4%	+24.9%	+28.1%	+26.3%	-	+16.4%	+9.7%	+16.2%
ILMN Dec	+8.0%	+14.8%	+21.1%	+6.3%	−8.6%	+39.7%	+1.3%	−1.7%	−2.9%	−0.7%
WST Dec	+7.8%	+6.0%	+7.4%	+7.1%	+16.7%	+31.9%	+2.0%	+2.2%	−1.9%	+6.3%
WAT Dec	+6.1%	+6.5%	+4.8%	−0.6%	−1.7%	+17.8%	+6.7%	−0.5%	+0.1%	+7.0%
IDXX Dec	+10.8%	+10.9%	+12.4%	+8.8%	+12.5%	+18.8%	+4.7%	+8.7%	+6.5%	+10.4%
PODD Dec	+39.1%	+26.4%	+21.6%	+30.9%	+22.5%	+15.1%	+18.8%	+30.0%	+22.1%	+30.7%
Peer median	+8.7%	+10.9%	+18.4%	+7.1%	+2.7%	+20.5%	+5.1%	+3.4%	+3.5%	+6.3%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	-	-	-	-	-	-	-	-	-	-
ALGN Dec	75.5%	75.8%	73.6%	72.5%	71.3%	74.3%	70.5%	70.1%	70.0%	67.2%
MTD Dec	57.3%	57.8%	57.4%	57.9%	58.4%	58.4%	58.9%	59.2%	60.1%	59.4%
COO Oct	59.6%	63.9%	64.4%	66.2%	63.1%	66.9%	64.7%	65.6%	66.6%	65.5%
VEEV Jan	65.2%	68.5%	69.4%	71.6%	72.5%	72.8%	-	71.7%	71.3%	74.5%
ILMN Dec	69.5%	66.4%	69.0%	69.6%	68.0%	69.7%	64.8%	60.9%	65.4%	66.1%
WST Dec	33.2%	32.1%	31.8%	32.9%	35.8%	41.5%	39.4%	38.3%	34.5%	35.9%
WAT Dec	-	-	-	-	-	-	-	-	-	-
IDXX Dec	54.9%	55.7%	56.1%	56.7%	58.0%	58.8%	59.5%	59.8%	61.0%	61.8%
PODD Dec	57.5%	59.8%	65.7%	65.1%	64.4%	68.4%	61.7%	68.3%	69.8%	71.6%
Peer median	58.6%	61.8%	65.1%	65.6%	63.8%	67.7%	61.7%	63.3%	66.0%	65.8%

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	14.1%	15.5%	14.6%	13.4%	14.8%	16.7%	16.4%	14.9%	5.6%	0.6%
ALGN Dec	23.1%	24.0%	23.7%	22.5%	15.7%	24.7%	17.2%	16.7%	15.2%	13.5%
MTD Dec	-	-	-	-	-	-	-	-	-	-
COO Oct	16.5%	20.1%	15.9%	20.6%	12.8%	17.3%	15.3%	14.8%	18.1%	16.7%
VEEV Jan	19.2%	21.9%	22.9%	25.8%	25.9%	27.3%	-	21.3%	18.2%	25.2%
ILMN Dec	24.5%	22.0%	26.5%	27.8%	17.9%	−2.7%	−91.2%	−23.7%	−19.1%	18.6%
WST Dec	12.9%	14.1%	14.0%	16.1%	19.0%	26.6%	25.4%	22.9%	19.7%	19.0%
WAT Dec	28.8%	28.7%	30.6%	29.4%	27.3%	29.5%	29.4%	27.7%	27.9%	25.4%
IDXX Dec	19.7%	21.0%	22.2%	23.0%	25.7%	29.0%	26.7%	30.0%	29.0%	31.6%
PODD Dec	−2.9%	−1.6%	4.9%	6.8%	5.7%	11.5%	2.9%	13.0%	14.9%	17.5%
Peer median	19.5%	21.4%	22.5%	22.8%	18.4%	25.6%	17.2%	19.0%	18.1%	18.8%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	9.2%	6.6%	10.0%	9.6%	12.5%	11.0%	12.2%	11.5%	0.5%	−3.6%
ALGN Dec	17.6%	15.7%	20.4%	18.4%	71.8%	19.5%	9.7%	11.5%	10.5%	10.2%
MTD Dec	15.3%	13.8%	17.5%	18.6%	19.5%	20.7%	22.3%	20.8%	22.3%	21.6%
COO Oct	13.9%	17.4%	5.5%	17.6%	9.8%	100.8%	11.7%	8.2%	10.1%	9.2%
VEEV Jan	13.3%	14.1%	21.9%	26.7%	27.3%	23.1%	-	22.6%	22.2%	26.0%
ILMN Dec	19.3%	26.4%	24.8%	28.3%	20.3%	16.8%	−96.1%	−25.8%	−28.0%	19.6%
WST Dec	9.5%	9.4%	12.0%	13.1%	16.1%	23.4%	20.3%	20.1%	17.0%	16.1%
WAT Dec	24.1%	0.9%	24.5%	24.6%	22.1%	24.9%	23.8%	21.7%	21.6%	20.3%
IDXX Dec	12.5%	13.4%	17.0%	17.8%	21.5%	23.2%	20.2%	23.1%	22.8%	24.6%
PODD Dec	−7.9%	−5.8%	0.6%	1.6%	0.8%	1.5%	0.4%	12.2%	20.2%	9.1%
Peer median	13.9%	13.8%	17.5%	18.4%	20.3%	23.1%	15.9%	20.1%	20.2%	19.6%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	$261.6M	$235.6M	$301.1M	$340.4M	$380.0M	$532.0M	$294.9M	$365.4M	$501.6M	$518.5M
ALGN Dec	$177.1M	$242.8M	$331.4M	$597.6M	$507.3M	$771.4M	$276.8M	$608.1M	$622.7M	$490.8M
MTD Dec	$336.8M	$388.9M	$422.3M	$506.1M	$632.2M	$801.2M	$737.8M	$860.6M	$864.4M	$848.6M
COO Oct	$357.0M	$466.4M	$475.3M	$421.1M	$176.2M	$524.2M	$450.4M	$215.0M	$288.1M	$433.7M
VEEV Jan	$59.0M	$137.1M	$223.8M	$302.4M	$434.3M	-	-	-	-	-
ILMN Dec	$519.0M	$565.0M	$846.0M	$842.0M	$891.0M	$337.0M	$106.0M	$283.0M	$709.0M	$931.0M
WST Dec	$49.2M	$132.5M	$183.9M	$240.8M	$298.1M	$330.6M	$439.4M	$414.5M	$276.4M	$468.9M
WAT Dec	-	-	-	-	-	-	-	$442.2M	$619.6M	$539.8M
IDXX Dec	$274.2M	$298.9M	$284.3M	$304.2M	$541.1M	$636.0M	$394.1M	$772.9M	$808.1M	$1.1B
PODD Dec	−$6.2M	−$32.5M	−$121.5M	−$65.3M	−$45.0M	−$180.0M	−$3.9M	$70.1M	$305.3M	$377.7M
Peer median	$225.6M	$270.9M	$307.9M	$362.6M	$470.8M	$524.2M	$394.1M	$428.3M	$621.1M	$515.3M

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	15.6%	12.7%	13.3%	13.0%	13.0%	15.0%	7.4%	8.8%	12.4%	12.9%
ALGN Dec	16.4%	16.5%	16.9%	24.8%	20.5%	19.5%	7.4%	15.7%	15.6%	12.2%
MTD Dec	13.4%	14.3%	14.4%	16.8%	20.5%	21.6%	18.8%	22.7%	22.3%	21.1%
COO Oct	18.2%	21.8%	18.8%	15.9%	7.2%	17.9%	13.6%	6.0%	7.4%	10.6%
VEEV Jan	14.4%	24.9%	32.4%	35.1%	39.3%	-	-	-	-	-
ILMN Dec	21.6%	20.5%	25.4%	23.8%	27.5%	7.4%	2.3%	6.3%	16.2%	21.4%
WST Dec	3.3%	8.3%	10.7%	13.1%	13.9%	11.7%	15.2%	14.1%	9.6%	15.3%
WAT Dec	-	-	-	-	-	-	-	15.0%	20.9%	17.1%
IDXX Dec	15.4%	15.2%	12.8%	12.6%	20.0%	19.8%	11.7%	21.1%	20.7%	24.6%
PODD Dec	−1.7%	−7.0%	−21.6%	−8.8%	−5.0%	−16.4%	−0.3%	4.1%	14.7%	13.9%
Peer median	14.9%	15.8%	15.6%	16.3%	20.2%	17.9%	11.7%	14.5%	15.9%	16.2%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	18.5%	11.8%	17.2%	15.4%	17.2%	15.4%	16.3%	13.2%	0.6%	−4.6%
ALGN Dec	19.0%	20.0%	31.9%	32.9%	54.9%	21.3%	10.0%	12.3%	10.9%	10.1%
MTD Dec	88.4%	68.7%	86.9%	133.3%	n/m	n/m	n/m	n/m	n/m	n/m
COO Oct	10.2%	11.7%	4.2%	12.9%	6.2%	42.4%	5.4%	3.9%	4.9%	4.6%
VEEV Jan	10.4%	11.4%	16.7%	18.6%	18.1%	14.7%	-	13.1%	11.3%	12.2%
ILMN Dec	21.1%	26.4%	22.0%	21.7%	14.0%	7.1%	−66.7%	−20.2%	−51.5%	31.2%
WST Dec	12.9%	11.8%	14.8%	15.4%	18.7%	28.3%	21.8%	20.6%	18.4%	15.5%
WAT Dec	22.7%	0.9%	37.9%	n/m	n/m	188.5%	140.3%	55.8%	34.9%	25.1%
IDXX Dec	n/m	n/m	n/m	n/m	92.0%	107.9%	111.6%	56.9%	55.7%	66.0%
PODD Dec	−45.8%	−16.9%	1.6%	15.3%	1.1%	3.0%	1.0%	28.2%	34.5%	16.3%
Peer median	15.9%	11.8%	19.3%	18.6%	18.1%	24.8%	10.0%	16.9%	14.8%	15.9%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	1.41	1.04	1.22	1.15	0.93	1.05	0.91	0.74	0.65	0.68
ALGN Dec	-	-	-	-	-	-	-	-	-	-
MTD Dec	2.06	1.79	1.75	3.07	4.72	9.81	n/m	n/m	n/m	n/m
COO Oct	0.57	0.37	0.61	0.50	0.47	0.21	0.38	0.34	0.32	0.30
VEEV Jan	-	-	-	-	-	-	-	-	-	-
ILMN Dec	0.48	0.43	0.22	0.25	0.25	0.09	0.30	0.26	0.84	0.73
WST Dec	0.21	0.15	0.14	0.16	0.14	0.11	0.08	0.07	0.08	0.06
WAT Dec	0.85	0.89	0.73	n/m	5.86	4.14	3.13	2.05	0.89	0.55
IDXX Dec	n/m	n/m	n/m	3.94	1.44	1.23	1.26	0.47	0.39	0.28
PODD Dec	5.27	3.57	2.79	11.70	1.75	2.29	2.94	1.93	1.14	0.63
Peer median	0.71	0.66	0.67	1.79	1.44	1.23	0.82	0.41	0.61	0.43

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
CRL Dec	$3.23	$2.54	$4.62	$5.07	$7.20	$7.60	$9.48	$9.22	$0.20	−$2.91
ALGN Dec	$2.33	$2.83	$4.92	$5.53	$22.41	$9.69	$4.61	$5.81	$5.62	$5.65
MTD Dec	$14.22	$14.24	$19.88	$22.47	$24.91	$32.78	$38.41	$35.90	$40.48	$42.05
COO Oct	$1.40	$1.88	$0.70	$2.33	$1.20	$14.79	$1.94	$1.48	$1.96	$1.87
VEEV Jan	$0.38	$0.53	$0.98	$1.47	$1.90	$2.63	-	$3.00	$3.22	$4.32
ILMN Dec	$3.07	$4.92	$5.56	$6.74	$4.45	$5.04	−$28.00	−$7.34	−$7.69	$5.45
WST Dec	$1.91	$1.99	$2.74	$3.21	$4.57	$8.67	$7.73	$7.88	$6.69	$6.79
WAT Dec	$6.41	$0.25	$7.65	$8.69	$8.36	$11.17	$11.73	$10.84	$10.71	$10.76
IDXX Dec	$2.44	$2.94	$4.26	$4.89	$6.71	$8.60	$8.03	$10.06	$10.67	$13.08
PODD Dec	−$0.48	−$0.46	$0.05	$0.19	$0.10	$0.24	$0.07	$2.94	$5.78	$3.48
Peer median	$2.33	$1.99	$4.26	$4.89	$4.57	$8.67	$6.17	$5.81	$5.78	$5.65

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out CRL and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Work on CRL in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/CRL/export.csv") into a cell.